Cargando…
Fluvoxamine for symptomatic outpatients with COVID-19
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
CMA Impact Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863199/ https://www.ncbi.nlm.nih.gov/pubmed/35045990 http://dx.doi.org/10.1503/cmaj.220011 |
| _version_ | 1784655187094274048 |
|---|---|
| author | Wu, Peter E. Austin, Emily Leong, Derek |
| author_facet | Wu, Peter E. Austin, Emily Leong, Derek |
| author_sort | Wu, Peter E. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8863199 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | CMA Impact Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-88631992022-02-25 Fluvoxamine for symptomatic outpatients with COVID-19 Wu, Peter E. Austin, Emily Leong, Derek CMAJ Practice CMA Impact Inc. 2022-02-22 2022-02-22 /pmc/articles/PMC8863199/ /pubmed/35045990 http://dx.doi.org/10.1503/cmaj.220011 Text en © 2022 CMA Impact Inc. or its licensors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY-NC-ND 4.0) licence, which permits use, distribution and reproduction in any medium, provided that the original publication is properly cited, the use is noncommercial (i.e., research or educational use), and no modifications or adaptations are made. See: https://creativecommons.org/licenses/by-nc-nd/4.0/ |
| spellingShingle | Practice Wu, Peter E. Austin, Emily Leong, Derek Fluvoxamine for symptomatic outpatients with COVID-19 |
| title | Fluvoxamine for symptomatic outpatients with COVID-19 |
| title_full | Fluvoxamine for symptomatic outpatients with COVID-19 |
| title_fullStr | Fluvoxamine for symptomatic outpatients with COVID-19 |
| title_full_unstemmed | Fluvoxamine for symptomatic outpatients with COVID-19 |
| title_short | Fluvoxamine for symptomatic outpatients with COVID-19 |
| title_sort | fluvoxamine for symptomatic outpatients with covid-19 |
| topic | Practice |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863199/ https://www.ncbi.nlm.nih.gov/pubmed/35045990 http://dx.doi.org/10.1503/cmaj.220011 |
| work_keys_str_mv | AT wupetere fluvoxamineforsymptomaticoutpatientswithcovid19 AT austinemily fluvoxamineforsymptomaticoutpatientswithcovid19 AT leongderek fluvoxamineforsymptomaticoutpatientswithcovid19 |